Please login to the form below

Not currently logged in
Email:
Password:

Finland's Faron Pharmaceuticals appoints new medical director

Dr Matti Karvonen brings experience from Roche, Biogen and Novartis

Faron Pharmaceuticals Dr Matti KarvonenDr Matti Karvonen has moved from Roche to join Finland's Faron Pharmaceuticals as its new medical director.

He previously served as Roche's European medical lead and prior to that held roles with Novartis and Biogen, as well as several consultancies.

Dr Karvonen has a background in clinical neurology and in the early part of his career he held several research positions, including as research director for the University of Turku's Clinical Research Services Turku (CRST) unit.

In his new role he will join Turku-based Faron's executive management team and oversee its drug development strategy, including its clinical programmes for Traumakine and Clevegen.

Dr Markku Jalkanen, CEO of Faron, said: “We are delighted to welcome Dr Karvonen to our ambitious executive management team. His appointment comes at an important time for Faron as we expand our clinical activities.

“Our lead drug candidate Traumakine, for the treatment of Acute Respiratory Distress Syndrome (ARDS) is now in a pan-European phase III INTEREST trial, while clinical development for Clevegen, our novel cancer immunotherapy drug candidate is under active planning.”

13th May 2016

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

digital launch
How can virtual pharma companies de-risk new product launches?
The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market...
Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...

Infographics